Without a doubt, this has been a year of changes for the AMSlab Group.
Acquisition of AMSfashion by Bureau Veritas, creation of new companies such as Nexotech Technology, new sectors that we are targeting, new corporate identity, new facilities in progress… In short, a series of changes that indicate that we are more alive than ever and that we continue to grow and evolve.
With all this, our website also needed a change, it needed to be updated and reoriented towards a corporate website that brings together the reality of our day-to-day and the companies that make up the group.
Well, after months of work, we can finally say that today, Tuesday 11 July 2023, we have published our new corporate website!
A simple but well-structured website full of interesting content that reflects the trajectory, values, and mission of our business group, made up of a total of 5 biotech companies from different sectors (AMSvet, AMSbiopharma, Cifga, Nexotech Technology and AMSfood).
The aim of this project has been none other than to adapt the website to our new corporate identity and to the structural changes we have undergone in recent months, focusing also on improving usability and communication with our customers.
A more visual and faster website, in which the colour blue, associated with the health sector, predominates.
New features include a new, simple, and more elegant design, a directory that brings together all the companies in the group, a contact form segmented by sectors and departments that will facilitate communication with the client or user, and an employment section that gains more visibility by placing it in the main menu.
At AMSlab we attach great importance to attracting talent, so this point seemed essential to us.
We have also integrated this section with the Biotalent platform of the Bioga Cluster. This is a tool specialized in the management of recruitment processes for personnel with a biotechnological profile.
With all these changes, this website will be a meeting point for our customers, suppliers, organizations, future colleagues, and the entire biotech ecosystem.